What is the Accelerating Commercialisation?

Accelerating Commercialisation is focused on helping start-up companies commercialise new technology.

Accelerating Commercialisation, formally called Commercialisation Australia, helps Australian entrepreneurs, researchers, inventors, start-ups, Commercialisation Offices and small and medium enterprises address the challenges associated with commercialising novel intellectual property.

Accelerating Commercialisation is a key offering under the Entrepreneurs’ Programme.

The objective of Entrepreneurs’ Programme is to drive business growth and competitiveness through support for business improvement and promoting economic growth through research connections and commercialisation.


Want to find out my tips to get the
Accelerating Commercialisation grant?

Accelerating Commercialisation



The objectives of the Accelerating Commercialisation program are:

  • Speed to market – accelerating the commercialisation of novel intellectual property in the form of novel products, processes and services
  • Entrepreneurship – creating new businesses based on novel intellectual property with high growth potential
  • Return on Investment – facilitating greater commercial and economic returns from both public and private research and development investment to drive business growth and competitiveness
  • Research – generate greater commercial and economic returns from both public and private sector research


How much can you get?

This Accelerating Commercialisation grant provides projects up to 50% of the expenditure to a maximum of:

  • $250,000 for commercialisation offices and eligible partner entities
  • $1,000,000 for all other applicants.

Accelerating Commercialisation Grant recipients will also receive Portfolio Services for the duration of the project.


Eligible Projects

Eligible Accelerating Commercialisation projects aim to achieve at least one of the following:

  • Opportunity – Engage external professionals, for example to confirm the market opportunity, develop the business model, identify potential partners, develop an IP strategy, raise capital or prepare an Information Memorandum
  • Development – Complete development of a novel product, process or service
  • Viability – Prove commercial viability of a novel product, process or service to a customer, investor or strategic partner
  • Sales – Make the first sales of the novel product, process or service in Australia or overseas
  • Management – Engage a senior experienced executive to fill a key gap in the management team, which is essential to achievement of your commercialisation outcomes

Stage 1 – Expression of Interest

After you lodge your Accelerating Commercialisation EOI, a Commercialisation Advisor will review your proposal.

During the review of your EOI you may be asked for further information in support of your EOI.

The Commercialisation Adviser will provide you with initial guidance on your commercialisation project if you are considering an Accelerating Commercialisation Grant or your Commercialisation Strategy if you are considering a Portfolio Services application.

If you want to progress to a full Accelerating Commercialisation application, you may receive further feedback on the potential merits of your project or strategy.

You may receive this guidance and feedback in the form of a face-to-face meeting, a telephone conversation or other means of communication – whichever is most appropriate under the circumstances.


Stage 2 – Full Application

If you are invited to submit a full application for Accelerating Commercialisation you will need to score well on the following merits:

  • Need for Funding – you need to demonstrate insufficient financing to fund the entire project and that it would be unreasonable to expect you to obtain funding from from alternative sources.
  • Market Opportunity – the market need for the novel product, process or service is clearly defined. The strength of the IP (including novelty) has been well described.
  • Value Proposition – A clear, concise and compelling value proposition, i.e. why the intended customer wants to buy the product, process or service.
  • Execution Plan – A sound execution plan to capture the opportunity and manage the risks, including a clear set of objectives and a clearly defined path to market
  • Management Capability – The applicant demonstrates an appropriate level of expertise in commercialisation management, project management and business management
  • National Benefits – The project will improve Australia’s participation and competitiveness in the global economy.

Accelerating Commercialisation

Over $100 million has been given out.
How can you get some?


But what if you already have sales?

Accelerating Commercialisation Grants cannot be used to support projects beyond the point of first sales. This is because if it can be proven that your company and its novel product, process or service can be sold commercially in a key market, then financing is more readily available.

First sales means that a company is able to demonstrate, consistent with its value proposition, market acceptance of its novel product, process or service in its key target market(s).

A Accelerating Commercialisation project that aims to make first sales or other commercial transactions in an overseas market is unlikely to be competitive unless:

  • the overseas market is a key market for the novel product, process or service
  • the need for funding is clearly established, especially where your novel product, process or service has already been sold in Australia.


Commercialisation Advisors

If you apply to Accelerating Commercialisation, you will be connected to a Commercialisation Adviser.

Commercialisation Advisers are independent, professional advisers who will guide you along the pathway to commercialising your IP.

They can assist you by:

  • Guidance – providing guidance with respect to Accelerating Commercialisation
  • Access – assessing your needs and helping you to access expertise and specialist advice
  • Assistance – guiding and assisting you through the commercialisation process
  • Funding – exploring alternative means of financing your project
  • Operations – guiding and assisting you in operational matters
  • Mentoring – monitoring your progress
  • Network – developing your professional networks, including by linking you to members of the Expert Network.

Each Commercialisation Adviser has extensive experience in commercialisation either having taken their own products, processes or services to market, or having held senior roles in companies commercialising novel products, processes or services.


Expert Network

The Accelerating Commercialisation Expert Network is a network of experienced people who can help you make important business connections and create opportunities for you to raise capital and enter new markets.

Members of the Expert Network include successful entrepreneurs, domain experts, professional investors and strategic corporations. They have extensive experience in management, commercialisation, capital markets and business development. Members offer knowledge, skills, insights and links to help you in bringing your novel product, process or service to market.

The Expert Network builds upon the support you will receive from your Commercialisation Advisers as a growing resource to help you reach the people you need to reach – faster.


More Information


Software Commercialisation Examples

Supashock – $468,887

Motor Sport and Defence Industries

Supashock has teamed up with German defence vehicle manufacturing giant Rheinmetall. The partnership has been very collaborative and a testament to a close working strategic and technical relationship which has developed technology for Advanced Defence vehicle applications.

Supashock’s Accelerating Commercialisation Grant of $468,887 has assisted greatly in providing a platform for this technology for wheeled defence vehicles and helped Supashock continue to provide world leading suspension technologies for defence vehicles.

Baraja – $1M

LiDAR – for safer driverless car technology

Sydney firm Baraja Pty Ltd (Baraja) has taken its staff numbers from just five to a staggering 95, as it breaks new ground in the self-driving car revolution. Baraja has also raised A$45M Series A in capital since founding the company.

Baraja’s 3D LiDAR is a step further as the firm’s brilliant minds have overcome many of LiDAR’s previous limitations and developed a sensor capable of being scaled up to automotive volumes and down to automotive prices.

Inventia – $760,000

3D bioprinter – to print human cells

Inventia Life Science’s Pty Ltd created a 3D bioprinter that is transforming our understanding of human cell behaviour and drug development, with the help of many, including Accelerating Commercialisation support. The Sydney based Rastrum platform enables scientists working in fields such as cancer research and regenerative medicine, to print living cells and biomaterials in 3D environments that mimic the human body.

Osler Technology – $1.1M

Clinical Performance Platform

Osler Technology has developed a Clinical Performance Platform for medical practitioners to record, monitor and analyse their clinical practice. By ensuring clinicians are appropriately trained using mobile technology at the patient bedside, Osler Technology reduces preventable patient harm that results in additional operational cost, litigation and human toll across health systems. Accelerating Commercialisation support will be used to help Osler Technology Pty Ltd complete and secure further Beta trials; complete the development of the application’s commercial release, secure its first commercial customers and; develop an entry plan for international markets.

Advanced Agricultural Systems – $1.1M

SwarmFarm – The key to unlocking new farming systems

Advanced Agricultural Systems has developed autonomous, robotic machines for use in agriculture. This technology will save on labour, reduce farm costs, increase yields, use inputs more efficiently and reduce the environmental impacts of agriculture. The commercial weed spraying project is the key step towards the overall commercialisation of robots as part of a new proven farming system. Accelerating Commercialisation support will be used to help SwarmFarm commercialise agricultural robotics and create a new industry resulting in increased productivity, in both Australian and International agriculture.

The Yield Technology Solutions – $1.1M

Improving yields in the Oyster Industry

The Yield has developed innovative Internet of Things technology which is designed to improve oyster growers’ yields and profitability through reducing unnecessary harvest closures, improving labour scheduling and tracking food safety. Accelerating Commercialisation is helping The Yield commercialise its products enabling sales, investment and global licensing revenue. It will contribute to Australia’s global reputation for high quality food exports.

Bluedot Innovation  – $0.9M

Geolocation Software

Bluedot Innovation has developed novel location-based software enabling a new generation of local-based commerce.

Commercialisation Australia funding will be used to engage expert service providers to help build a commercial strategy, and to validate the performance and benefits of this software with key commercial partners.


Current Recipients

11 businesses including in the health, energy and commerce sectors will share in $4.6 million in of Accelerating Commercialisation funding as part of the Entrepreneurs’ Programme.

GenomiQa (QLD) will use its $479,405 of funding to commercialise its diagnostic platform to support oncologists to manage patient care. By mapping whole genomes the technology enables more targeted cancer management, which can improve outcomes for patients.

MGA Thermal has developed technology that stores renewable energy from the sun and wind as heat. The business will use its $495,600 of funding to ensure the technology is feasible on a commercial scale.

To encourage small to medium businesses to pay early, Zelo Trading has developed ZeloPay. The business will use its $282,159 of funding to commercialise its platform that automates, brokers, and incentivises early payments for B2B transactions which, in turn, can help businesses pay their rent and survive in the current environment.

The latest Accelerating Commercialisation grants will also assist:

  • Capsular Technologies Pty Ltd (VIC) with a grant of $165,000 to commercialise its biopolymer-based vaccines for the agricultural sector and help improve livestock health and productivity.
  • C & J Lab Pty Ltd (NSW) with a grant of $250,000 to commercialise its Green Feed Additive (GFA) that replaces the use of antibiotics in the livestock and aquaculture feed industries.
  • Flip Screen Australia Pty Ltd (NSW) with a grant of $824,791 to validate its manufacturing processes for their innovative on-site crushing system for the mining and recycling industries, that achieves high-volume crushing rates with larger ranges of crush sizes for sales in Australian and international markets.
  • Kynd Pty Ltd (QLD) with a grant of $492,225 to commercialise its disability support data platform and achieve a geographic rollout to deliver national benefits including increased access to disability services, decreased costs through technology efficiency and highly personalised matching of people.
  • Solar And Storage Modelling Pty Ltd (NSW) with a grant of $580,735 to deploy at scale a global nowcasting offering for the wind and temperature forecasting industry with potential benefits to the energy, transportation and insurance sectors.
  • University of Melbourne (VIC) with a grant of $200,000 for hardware and software development, user trials, IP protection, establishment of a commercial team and initial business development in Australian and international markets of their imaging tool that can detect tiny organisms such as viruses.
  • Vapar Innovation Pty Ltd (NSW) with a grant of $490,000 to commercialise its VAPAR web innovation that uses artificial intelligence to automate fault detection directly from the inspection footage of underground water pipes.
  • Workforce Health Assessors Pty Ltd (TAS) with a grant of $358,292 to commercialise Quescreen, its assessment solution for the employment market.